Core-Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems
- PMID: 36703085
- DOI: 10.1208/s12249-023-02504-z
Core-Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems
Abstract
Amongst the several nano-drug delivery systems, lipid or polymer-based core-shell nanocapsules (NCs) have garnered much attention of researchers owing to its multidisciplinary properties and wide application. NCs are structured core-shell systems in which the core is an aqueous or oily phase protecting the encapsulated drug from environmental conditions, whereas the shell can be lipidic or polymeric. The core is stabilized by surfactant/lipids/polymers, which control the release of the drug. The presence of a plethora of biocompatible lipids and polymers with the provision of amicable surface modifications makes NCs an ideal choice for precise drug delivery. In the present article, multiple lipidic and polymeric NC (LNCs and PNCs) systems are described with an emphasis on fabrication methods and characterization techniques. Far-reaching applications as a carrier or delivery system are demonstrated for oral, parenteral, nasal, and transdermal routes of administration to enhance the bioavailability of hard-to-formulate drugs and to achieve sustained and targeted delivery. This review provide in depth understanding on core-shell NC's mechanism of absorption, surface modification, size tuning, and toxicity moderation which overshadows the drawbacks of conventional approaches. Additionally, the review shines a spotlight on the current challenges associated with core-shell NCs and applications in the foreseeable future.
Keywords: core–shell; lipid; nanocapsules; nanoparticles; polymer; targeting.
© 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: in vitro and ex vivo evaluation.Drug Deliv. 2022 Dec;29(1):294-304. doi: 10.1080/10717544.2022.2026535. Drug Deliv. 2022. PMID: 35037528 Free PMC article.
-
Recent advances in polymer shell oily-core nanocapsules for drug-delivery applications.Nanomedicine (Lond). 2021 Aug;16(18):1613-1625. doi: 10.2217/nnm-2021-0037. Epub 2021 Jun 30. Nanomedicine (Lond). 2021. PMID: 34189946
-
Intravenous delivery of furosemide using lipid-based versus polymer-based nanocapsules: in vitro and in vivo studies.Pharm Dev Technol. 2024 Sep;29(7):738-750. doi: 10.1080/10837450.2024.2389855. Epub 2024 Aug 14. Pharm Dev Technol. 2024. PMID: 39105766
-
Applications of polymeric nanocapsules in field of drug delivery systems.Curr Drug Discov Technol. 2011 Sep;8(3):173-87. doi: 10.2174/157016311796799008. Curr Drug Discov Technol. 2011. PMID: 21644922 Review.
-
Nanocapsules: An Emerging Drug Delivery System.Recent Pat Nanotechnol. 2023;17(3):190-207. doi: 10.2174/1872210516666220210113256. Recent Pat Nanotechnol. 2023. PMID: 35142273 Review.
Cited by
-
Core-Shell PLGA Nanoparticles: In Vitro Evaluation of System Integrity.Biomolecules. 2024 Dec 14;14(12):1601. doi: 10.3390/biom14121601. Biomolecules. 2024. PMID: 39766308 Free PMC article.
-
Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluation.Drug Deliv Transl Res. 2023 Oct;13(10):2614-2638. doi: 10.1007/s13346-023-01342-7. Epub 2023 Apr 17. Drug Deliv Transl Res. 2023. PMID: 37067745
-
Recent advances in nanomaterial-based drug delivery systems for melanoma therapy.ADMET DMPK. 2023 Oct 24;12(1):107-150. doi: 10.5599/admet.2088. eCollection 2024. ADMET DMPK. 2023. PMID: 38560710 Free PMC article. Review.
-
Exploring the therapeutic potential of lipid-based nanoparticles in the management of oral squamous cell carcinoma.Explor Target Antitumor Ther. 2024;5(6):1223-1246. doi: 10.37349/etat.2024.00272. Epub 2024 Sep 29. Explor Target Antitumor Ther. 2024. PMID: 39465011 Free PMC article. Review.
-
The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics.AAPS PharmSciTech. 2024 Nov 5;25(8):265. doi: 10.1208/s12249-024-02977-6. AAPS PharmSciTech. 2024. PMID: 39500822 Review.
References
-
- Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MdP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018;16(1):1–33.
-
- Singh A, Handa M, Ruwali M, Flora S, Shukla R, Kesharwani P. Nanocarrier mediated autophagy: an emerging trend for cancer therapy. Process Biochem. 2021;109:198–206.
-
- Varma LT, Singh N, Gorain B, Choudhury H, Tambuwala MM, Kesharwani P, et al. Recent advances in self-assembled nanoparticles for drug delivery. Curr Drug Deliv. 2020;17(4):279–91.
-
- Mhaske A, Singh S, Abourehab MA, Kumar A, Kesharwani P, Shukla R. Recent pharmaceutical engineered trends as theranostics for Japanese Encephalitis. Process Biochemistry. 2022.
-
- Ghaffari M, Dolatabadi JEN. Nanotechnology for pharmaceuticals. Industrial Applications of Nanomaterials. Elsevier; 2019. p. 475–502.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources